Clinical Trial Update: An Open-Label Long-term Safety Study of Tramadol HCl OAD (Once A Day) 300 mg in the Treatment of Pain Due to Osteoarthritis of the Knee [Phase 3]

View source ↗

Summary

This is an open-label long-term safety study of once-daily tramadol hydrochloride 300 mg for pain due to osteoarthritis of the knee. The Phase 3 trial has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Tramadol HCl OAD 300 mg (tramadol hydrochloride)

Snippet

Sponsor: Labopharm Inc. | Conditions: Osteoarthritis, Knee | Phase 3 | Status: COMPLETED | Results posted: 2009-06-02